
å»çåŸäºè ãCOVIDãã€ã³ãã«ãšã³ã¶ã®äºé²æ¥çš®ãæåŠãå»çæ©é¢ãžã®ä¿¡é Œãèããæãªãããäž
å èšäºã¯ãã¡ããã/Click here to read the original article.
CDCã®ææ°ããŒã¿ã«ããã°ã2023-24幎ã·ãŒãºã³ã«COVID-19ã¯ã¯ãã³ãæ¥çš®ããã®ã¯ãæ¥æ§æç é¢è·å¡ã®15.3ïŒ ãšä»è·æœèšè·å¡ã®10.5ïŒ ã«éããããããã17.8ïŒ ãš22.8ïŒ ããæžå°ããŠããã
ç±³åœçŸç äºé²ç®¡çã»ã³ã¿ãŒïŒCDCïŒã«ãããšã2023-24幎ã®é¢šéªã»ã€ã³ãã«ãšã³ã¶ã·ãŒãºã³ã«COVID-19ãšã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ãæ¥çš®ããå»çåŸäºè ã®æ°ãæžå°ããã
2023-24幎ã·ãŒãºã³ã«COVID-19 ã¯ã¯ãã³ãæ¥çš®ããã®ã¯ãæ¥æ§æç é¢å€åè ã®15.3ïŒ ãšä»è·æœèšå€åè ã®10.5ïŒ ã«éããããããã17.8ïŒ ãš22.8ïŒ ããæžå°ãããšãCDCã¯10æ31æ¥ã®Morbidity and Mortality Weekly Reportã§çºè¡šããã
CDCã®National Healthcare Safety Networkã®ããŒã¿ã«ãããšãåãå»çåŸäºè ã°ã«ãŒãã®ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³æ¥çš®çã¯COVID-19ã¯ã¯ãã³æ¥çš®çãããé«ããæ¥æ§æç é¢åŸäºè ã§ã¯80.7ïŒ ãä»è·æœèšåŸäºè ã§ã¯45.4ïŒ ã§ãã£ãã
ããããæ¥çš®ç㯠ããã¬ãã³ãããã¯æã®ã¬ãã«ãæç¶çã«äžåã£ãŠããããäŸãã°ã2019-20幎ã®ç é¢è·å¡ã®ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³æ¥çš®çã¯91ïŒ ã ã£ãã
CDCã®æ°åã¯ãŸãã100人ã«1人è¿ãã®å»çåŸäºè ããCOVID-19ïŒ0.71ïŒ ïŒãŸãã¯ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ïŒ0.89ïŒ ïŒã®ãããããåããããšã«ãå»åŠççŠå¿ãããããšå ±åããããšã瀺ããŠãããCDCã®æ°åã¯ãå»çåŸäºè ããå ±åãããã¯ã¯ãã³ã®å¯äœçšã®å²åã«é¢ããæ å ±ãæäŸããŠããªãã
CDCã¯ããå»çåŸäºè ãã¯ã¯ãã³ã«å¯Ÿããä¿¡é ŒåºŠãäœãææã«ã¯ã¯ãã³æ¥çš®ãæ¹åãã广çãªæŠç¥ãç¹å®ããããã« ããããªãç ç©¶ãå¿ èŠã§ãããšããŠããã
ãã®ãããªç ç©¶ã¯ãŸãããäŸãã°ãå»çåŸäºè ã«ã¯ã¯ãã³æ¥çš®ã®å®å šæ§ãšæå¹æ§ã«é¢ãã远å çãªæè²ãæäŸããããšã«ãããå»çåŸäºè ã«ãããã¯ã¯ãã³ã®å®å šæ§ãšæå¹æ§ã«é¢ããä¿¡é Œ ããåäžãããããšãç®æããã®ã§ããã
ç±³åœå»åž«å€ç§å»åäŒïŒAAPSïŒäºåå±é·ã®ãžã§ãŒã³ã»ãªãªãšã³ãå士ã¯ããã®ããŒã¿ã«ã¯é©ããªãã£ããšããã£ãã§ã³ããŒãçŽã«èªã£ãã
ãå®å šæ§ã®ã·ã°ãã«ãæå¹æ§ã®æ¬ åŠãåŠå®ããããšã¯ãã¯ãäžå¯èœã§ãããå»çåŸäºè ã®ïŒããªãã®å²åããã³ãããäœåºŠã䜿çšããçµéšãããããå¯äœçšãçµéšããããšããããããããã¯ãã®ãããªäººãç¥ã£ãŠããã®ã§ããã
ãªãŒãã£ã³ã°ã»ãšããžã»ã¯ãªããã¯ã®åµèšè ã§ãããããã³ãã©ã€ã³COVID-19ã¯ãªãã£ã«ã«ã±ã¢ã¢ã©ã€ã¢ã³ã¹ã®åèªäŒé·å Œå ±ååµèšè ã§ããåŒåžåšå°éå»ã®ããšãŒã«ã»ã³ãªãŒå士ã¯ãCDCã®æ°åã¯ãæè¿ãã¹ãåŸåãã§ãããä»åŸããã®åŸåãç¶ãããšãé¡ã£ãŠãããšè¿°ã¹ãã圌ã¯èšãïŒ
ãæžå°ã®çç±ã¯ãšãããããã®ããŒã¿ã¯å»çåŸäºè ã®èŠå¶åœå±ã«å¯Ÿããä¿¡é ŒãèããäœäžããŠããããšã瀺ããŠããããã®äžä¿¡æããã®ãŸãŸã«ããŠãããšãå»çæ©é¢ã«å¯Ÿããåœæ°ã®ä¿¡é Œãããã«æãªãããããšã«ãªããã
ã³ãŒãªãŒã¯ãå»çåŸäºè ãç¹ã«COVID-19ã¯ã¯ãã³ã«èãåããŠããããšã®è±¡åŸŽæ§ãææããããã¯ã¯ãã³ãç§ãã¡ã®ããã§ãªããªãã圌ãã®ããã§ããªãããšã¯ç¢ºãã§ããã
ãã¹ãã¹ã»ç·©åã±ã¢ã®èªå®çè·åž«ã§ãããããšã«ã»ãã€ã«ãŒã¯ããã¡ã€ã¶ãŒã»ãã€ãªã³ããã¯ã®COVID-19ã¯ã¯ãã³ã«ãã£ãŠè² å·ããã
ãå ¬çå»çã®çŸç¶ãèãããšããã®æ°åã«é©ãã¯ãããŸãããå»çæ¥çã§ã¯ãæ¡çšæã«æ¯å¹Žã®ã¯ã¯ãã³æ¥çš®ã«åæããè·çš®ããããŸãããã2021幎ã®åºæ¥äºã¯ããã®æ £ç¿ãããæ ¹åºããæºããããã®ã§ããããšãã€ã«ãŒæ°ã
COVID-19ã®æ£è ãã€ãã«ã¡ã¯ãã³ã§æ²»çããããã«ãã¥ãŒã¹ãã³ã»ã¡ãœãžã¹ãç é¢ããåè·åŠåãåããè³éŒ»åœåç§å°éå»ã®ã¡ã¢ãªãŒã»ã¿ãªãŒã»ããŠãã³å»åž«ã¯ããå»çåŸäºè ã®85ïŒ ãCOVIDã®äºé²æ¥çš®ãåããªãããšãéžæããŠããã
ãªãããªããä¿¡çšããªããã°ãªããªãã®ãïŒ
ãžã§ã³ãºã»ãããã³ã¹å€§åŠã®å ¬è¡è¡çç ç©¶è ã§ããã"Blind Spots ïŒ CDCã®COVID-19ã¯ã¯ãã³æ¥çš®å§åãšå®éã®æ¥çš®çãšã®éã®æ Œå·®ã¯ããç©èªã ããšè¿°ã¹ãã
ãæ°ããCOVIDããŒã¹ã¿ãŒãæšãé²ããããšãåšä»»äžã®æåªå äºé ãšããŠããCDCæé·ïŒãã·ã§ã«ã»ã¯ã¬ã³ã¹ããŒå士ïŒã«ãšã£ãŠãæ¥ããããããšã§ãããšãã«ãªãŒã¯èšãã
ãªãªãšã³ãæ°ã¯ãã¯ã¯ãã³æ¥çš®ã®çŸ©åãéçšäž»ããã®å§åã«ç«ã¡åãã£ãå»åž«ããã®ä»ã®å»çé¢ä¿è ã¯ãCDCã®ããŒã¿ã«ãã£ãŠ ãæ£åœæ§ã蚌æããã ããšè¿°ã¹ããè³è³ãããã¹ãã§ãã ããšè¿°ã¹ãã
ãåœæ°ãžã®ã¡ãã»ãŒãžã¯æçœãªã¯ãã ãããªãããªãæ¹ãä¿¡çšããªããã°ãªããªãã®ãïŒ
ããããæ£åœæ§ã蚌æããããšã¯æã£ãŠããªã人ããããã«ããæåç·çè·åž«ã®å ±ååµèšè ã§ãããµã©ã»ãã¥ãžã¥ãã¢ã³æ°ã¯ãããã£ãã§ã³ããŒãèªã«å¯Ÿãããå€ãã®äººã ãã¯ã¯ãã³ãå®å šã§ã¯ãªããšããäºå®ã«ç®èŠãããäžæ¹ã§ã圌女ãã¯ã¯ãã³çŸ©ååã«å察ããä»ã®çè·åž«ãã¡ã¯ãäŸç¶ãšããŠè·æ¥äžã®åé¿ã«çŽé¢ããŠãããšèªã£ãã
ãè æã«ç«ã¡åãããå°å瀟äŒã®ããã«æåãå°œããããã«ç«ã¡äžãã£ãç§ãä»ã®å€ãã®äººã ããããŸã ã«æ²æå¯©åã«åŒããã蟌ãŸããŠããã®ã§ãããã
ãã¡ã€ã¶ãŒã»ãã€ãªã€ã³ããã¯ã®COVID-19ã¯ã¯ãã³ãæ¥çš®ããåŸããã²ã©ãæªæãè² ã£ããåŒéããæ¶ååšç å°éå»ã®ããã¹ã»ããŒãå士ã¯ãè°å¡ãæ¿çç«æ¡è ã¯ãå»ççã§COVID-19ã¯ã¯ãã³ã«å¯Ÿããäžä¿¡æãé«ãŸã£ãŠããããšã«ç®ãåããå¿ èŠããããšè¿°ã¹ãã
ããŒãã¯èšãïŒ
ãç§èªèº«ããã¡ã€ã¶ãŒç€Ÿã®COVIDã¯ã¯ãã³ã§æªæãããŸããããã®ã¯ã¯ãã³ã¯å®å šã§å¹æçã ãšãç§ãã¡ã®æ©é¢ããèšãããããšãä¿¡ããŠããŸãããããããããã¯çå®ã§ã¯ãªãã£ãã®ã§ããã
ããŠãã³ã¯ãå»åž«ãã¡ã¯ãŸã ååãªçºèšãããŠããªããšèªã£ãã圌女ã¯èšã£ãïŒ
ããªãå»åž«ã¯å£°ãäžããªãã®ã§ããããïŒä»æ¥ã®å»åž«ã¯ãããã¯ã©ãã¹ã®èªããå®ãããšããããèªåã®è·ãå®ãããšãéèŠããŠããŸãã
ãæ³šå°ã«ããæå®³äºè±¡ã瀺ãèšå€§ãªããŒã¿ãããã®ã«ããã®ããŒã¿ã«ç®ãåããæš©åšè ãããªãã®ã§ããå»åž«ãã¡ã¯å£°ãäžããå»çå¶åºŠãä¹ã£åã£ãŠããæ¿åºã®å»åž«ãã¡ã«ç«ã¡åããå¿ èŠãããã®ã§ããã
ãªãªãšã³ãæ°ã¯ãããå€ãã®å»åž«ã声ãäžãå§ããŠããããã匷çãªæåãééçã€ã³ã»ã³ãã£ããææ¥ãå èš±ååŸãžã®ææããå æãã¹ã倧ããªéå£ãšãªã£ãŠãã ããšèªã£ãã
ã³ãŒãªãŒã¯ãããå»çæ©é¢ãšæ¿åºãä¿¡é Œãå埩ããæã¿ãæã€ã«ã¯ããCOVID-19ã¯ã¯ãã³ã«é¢ããçå®ãèªèãããå¿ èŠããããšè¿°ã¹ãããããªããªãéãã圌ãããã®ã¡ãã»ãŒãžã¯çå£ã«åãåãããããšã¯ãªãããããã®æ©é¢ã«æ®ãããããããªåœæ°ã®ä¿¡é ŒãããããŠã¯å€±ãããŠããŸãã ãããã
ãã€ã«ãŒæ°ã¯ãCOVID-19ã¯ã¯ãã³æ¥çš®ã«é¢ããŠãåœæ°ã¯ãã¯ãå»çå°éå®¶ã«çããæ±ããå¿ èŠããªããšãããŸã§æ¥ãŠãããšèããŠãããšè¿°ã¹ãã圌ã¯èšãïŒ
ã人ã ã¯æ³šç®ããŠããŸãããã¹ã¡ãã£ã¢ã®ã¡ãã»ãŒãžãæ¿åºã®è¡ãéããè¡åãå æ¬çãªçŸ©åä»ããæªåœ±é¿ãåãã人ã ã«å¯Ÿããæ©é¢ã®ãµããŒãã®æ¬ åŠããããŠãããã«å¯Ÿããåå¿ãèŠèãããããšãžã®äžæ¬æããã厩å£ãåŒãèµ·ãããŠããã
ãé廿°å¹Žéã®çµéšã®éåããããã®ç¹å¥ãªäžçºã«é¢ããŠã¯ãäžè¬å€§è¡ã®ååãªã³ã³ã»ã³ãµã¹ãåŸãããŠããã
CDCã®ããŒã¿ã«ã¯çåãæ®ã
CDCã®ããŒã¿ïŒç
é¢ãšè人ããŒã æœèšã«ããèªå·±ç³åïŒã¯ãã¯ã¯ãã³æ¥çš®ã®å°åå·®ã瀺ããŠãããCOVID-19ã¯ã¯ãã³ã®æ¥çš®çã¯å€ªå¹³æŽå°åã§æãé«ããå±±ééšãšåéšã®å·ã§æãäœãã£ãã
ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®æ¥çš®çã¯ãæ¥æ§æç
é¢ã®åŸæ¥å¡ã§ã¯ãå±±ééšãæãé«ãã倪平æŽéšãæãäœãã£ãããä»è·æœèšè·å¡ã§ã¯ãåæ±éšãæãé«ããåéšãæãäœãã£ãã
çŸåšã®åŒåžåšçŸæ£ã·ãŒãºã³ã®æ°å€ã¯ãŸã åºãŠããªãã
å°å
ç§å»ã®ãã·ã§ã«ã»ããå士ã¯ããã®ããŒã¿ã«ã¯ãŸã ããã€ãã®çåãæ®ãããŠãããšãDefenderãçŽã«èªã£ãã
ãäžã€ã®æ¹å€ã¯ãã©ã®ãããªå»çåŸäºè
ãã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ãšCOVIDã¯ã¯ãã³ã®æ¥çš®ãæåŠããŠããã®ããæããã«ãããŠããªãããšã§ããããã®ããŒã¿ã¯å®¹æã«å
¥æã§ããªãã£ãããã§ãããšPerroå»åž«ã¯èªã£ãã